Editorial pages weigh in on a range of public health topics stemming from gun violence. The Wall Street Journal: Guns And The Do-Something Fallacy “Do something!” someone shouted at Ohio Gov. Mike DeWine. The shout came during a candlelight vigil in downtown Dayton, where a disturbed young man just hours before had shot to death… Read More »
By Robert Preidt HealthDay Reporter THURSDAY, Jan. 31, 2019 (HealthDay News) — The first generic version of the widely used Advair Diskus inhaler for asthma and chronic obstructive pulmonary disease (COPD) has won U.S. Food and Drug Administration approval. This approval “is part of our longstanding commitment to advance access to lower cost, high-quality generic… Read More »
Copyright © 2018 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions. Latest articles from News
Casting aside their earlier wariness, health system executives are delving into cloud computing. The reasons for their shift in thinking include their desire to cut data center costs, deploy new applications quickly, and access flexible and scalable resources for data storage and computing power. “Two and a half years ago when I got here, I… Read More »
Critics of Takeda’s $ 62 billion Shire buyout and Shire’s own investors have fretted lately about the company’s standing in the hemophilia market. But immunology is a different story. In the third quarter, the unit continued to post “strong growth,” as Jefferies analyst David Steinberg put it in a Thursday note to clients, with revenues… Read More »